Benlysta (belimumab) is used by people with active systemic lupus erythematosus (SLE) or lupus nephritis. It can be administered intravenously or as a subcutaneous injection.
Common side effects include
- Nausea
- Diarrhea
- Fever
- Stuffy or runny nose
- Sore throat
- Cough
- Trouble sleeping
- Leg or arm pain
- Show Full Answer
Benlysta (belimumab) is used by people with active systemic lupus erythematosus (SLE) or lupus nephritis. It can be administered intravenously or as a subcutaneous injection.
Common side effects include:
- Nausea
- Diarrhea
- Fever
- Stuffy or runny nose
- Sore throat
- Cough
- Trouble sleeping
- Leg or arm pain
- Depression
- Headache
- Discoloration, itching, pain, or swelling at the injection site
Rare but serious side effects include:
- Progressive multifocal leukoencephalopathy (a type of brain infection)
- Certain cancers
- Severe allergic reactions (anaphylaxis)
For more detailed information, you can refer to the source: [Benlysta (Belimumab) for Lupus | MyLupusTeam](https://www.mylupusteam.com/treatments/benlysta).
October 14, 2024